Tomohide Tsukahara
Overview
Explore the profile of Tomohide Tsukahara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
1575
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kashiwagi H, Shigehara K, Kubo T, Hirohashi Y, Mariya T, Matsuo K, et al.
Med Mol Morphol
. 2025 Mar;
PMID: 40082293
Placenta accreta spectrum (PAS) is a serious disease leading to complications and maternal death. The objective of the study was to characterize the placental villi and blood vessels of PAS...
2.
Sasaki K, Murata K, Minowa T, Shijubou N, Kobayashi H, Nakatsugawa M, et al.
Biochem Biophys Rep
. 2025 Mar;
41:101946.
PMID: 40046256
Inducing antigen peptide-specific cytotoxic T cells is challenging, partly due to the difficulty of maintaining the quality of antigen-presenting cells, such as dendritic cells. Consequently, artificial antigen-presenting cells (aAPCs) derived...
3.
Kato H, Tsukahara T, Murata K, Nishikata H, Mizue Y, Sasaya T, et al.
Cancer Immunol Immunother
. 2025 Mar;
74(4):133.
PMID: 40035876
The development of effective immunotherapies for solid tumors remains a significant challenge. In previous studies, we identified PVT1, a long non-coding RNA, with the peptide HF10 derived from PVT1, presented...
4.
Kikuchi N, Hatanaka S, Kubo T, Kamekura R, Kanda M, Kakuki T, et al.
Immunol Med
. 2025 Feb;
:1-7.
PMID: 39902902
Immunoglobulin G4-related disease (IgG4-RD) is a chronic inflammatory condition of unknown etiology characterized by lymphocytic infiltration, fibrosis, and infiltration of IgG4-positive plasma cells. It affects various organs, including the pancreas...
5.
Minowa T, Murata K, Mizue Y, Murai A, Nakatsugawa M, Sasaki K, et al.
Sci Transl Med
. 2024 Dec;
16(776):eadk8832.
PMID: 39630887
Acral lentiginous melanoma (ALM) is the most common melanoma subtype in non-Caucasians. Despite advances in cancer immunotherapy, current immune checkpoint inhibitors remain unsatisfactory for ALM. Hence, we conducted comprehensive immune...
6.
Nakahashi N, Emori M, Takada K, Murahashi Y, Shimizu J, Murase K, et al.
Hum Cell
. 2024 Dec;
38(1):25.
PMID: 39625530
Myxofibrosarcoma (MFS) is one of the most common soft-tissue sarcomas in elderly patients. Owing to the limited efficacy of chemotherapy and radiotherapy, complete resection is the only available curative treatment....
7.
Hori K, Yamada S, Murata K, Miyata H, Mizue Y, Murai A, et al.
Hum Vaccin Immunother
. 2024 Nov;
20(1):2414542.
PMID: 39539024
Adoptive T cell therapy, using T cell receptor-engineered T (TCR-T) cells and chimeric antigen receptor T (CAR-T) cells, is a potent immunotherapy option. Bladder cancer is a prevalent urological malignancy,...
8.
Tsunematsu R, Murai A, Mizue Y, Kubo T, Mariya T, Morita R, et al.
Cancer Genomics Proteomics
. 2024 Jun;
21(4):414-420.
PMID: 38944423
Background/aim: Clear cell carcinoma is a prevalent histological type of ovarian cancer in East Asia, particularly in Japan, known for its resistance to chemotherapeutic agents and poor prognosis. ARID1A gene...
9.
Kubo T, Asano S, Sasaki K, Murata K, Kanaseki T, Tsukahara T, et al.
HLA
. 2024 May;
103(5):e15472.
PMID: 38699870
Immunotherapy using immune checkpoint inhibitors (ICIs) has shown superior efficacy compared with conventional chemotherapy in certain cancer types, establishing immunotherapy as the fourth standard treatment alongside surgical intervention, chemotherapy, and...
10.
Shirosaki T, Kawai N, Ebihara Y, Murai A, Kubo T, Morita R, et al.
Anticancer Res
. 2024 Apr;
44(5):1877-1883.
PMID: 38677758
Background/aim: Human gastric cancer stem-like cells (CSCs)/cancer-initiating cells can be identified as aldehyde dehydrogenase-high (ALDH) cells. Cancer immunotherapy employing immune checkpoint blockade has been approved for advanced gastric cancer cases....